CID 14034279

Myricetin 3-o-[beta-d-glucosyl-(1->2)-alpha-l-rhamnoside]

Structural Information

Molecular Formula
C27H30O17
SMILES
C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C(=C4)O)O)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O
InChI
InChI=1S/C27H30O17/c1-7-16(33)21(38)25(44-26-22(39)20(37)18(35)14(6-28)42-26)27(40-7)43-24-19(36)15-10(30)4-9(29)5-13(15)41-23(24)8-2-11(31)17(34)12(32)3-8/h2-5,7,14,16,18,20-22,25-35,37-39H,6H2,1H3/t7-,14+,16-,18+,20-,21+,22+,25+,26-,27-/m0/s1
InChIKey
JRHHAUSYXYDKGJ-SEDTXNTKSA-N
Compound name
3-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

626.1483 Da
Monoisotopic Mass

-1.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 627.15558 234.1
[M+Na]+ 649.13752 234.8
[M+NH4]+ 644.18212 234.3
[M+K]+ 665.11146 241.1
[M-H]- 625.14102 227.9
[M+Na-2H]- 647.12297 254.1
[M]+ 626.14775 232.3
[M]- 626.14885 232.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.